These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19710359)

  • 1. Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome.
    Ishihara K; Amano K; Takaki E; Shimohata A; Sago H; Epstein CJ; Yamakawa K
    Cereb Cortex; 2010 May; 20(5):1131-43. PubMed ID: 19710359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
    Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
    Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards the understanding of Down syndrome using mouse models.
    Yamakawa K
    Congenit Anom (Kyoto); 2012 Jun; 52(2):67-71. PubMed ID: 22639990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome.
    Siarey RJ; Villar AJ; Epstein CJ; Galdzicki Z
    Neuropharmacology; 2005 Jul; 49(1):122-8. PubMed ID: 15992587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome.
    Llorens-Martín MV; Rueda N; Tejeda GS; Flórez J; Trejo JL; Martínez-Cué C
    Neuroscience; 2010 Dec; 171(4):1228-40. PubMed ID: 20875841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.
    Belichenko PV; Kleschevnikov AM; Salehi A; Epstein CJ; Mobley WC
    J Comp Neurol; 2007 Oct; 504(4):329-45. PubMed ID: 17663443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment.
    Lazic SE; Grote HE; Blakemore C; Hannan AJ; van Dellen A; Phillips W; Barker RA
    Eur J Neurosci; 2006 Apr; 23(7):1829-38. PubMed ID: 16623840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased lipid peroxidation in Down's syndrome mouse models.
    Ishihara K; Amano K; Takaki E; Ebrahim AS; Shimohata A; Shibazaki N; Inoue I; Takaki M; Ueda Y; Sago H; Epstein CJ; Yamakawa K
    J Neurochem; 2009 Sep; 110(6):1965-76. PubMed ID: 19645748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of neurogenesis in two neurogenic regions of APPswe/PS1dE9 transgenic mice.
    Niidome T; Taniuchi N; Akaike A; Kihara T; Sugimoto H
    Neuroreport; 2008 Sep; 19(14):1361-4. PubMed ID: 18766011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
    Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
    Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenesis decreases during brain maturation from adolescence to adulthood.
    He J; Crews FT
    Pharmacol Biochem Behav; 2007 Feb; 86(2):327-33. PubMed ID: 17169417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced adult neurogenesis and altered emotional behaviors in autoimmune-prone B-cell activating factor transgenic mice.
    Crupi R; Cambiaghi M; Spatz L; Hen R; Thorn M; Friedman E; Vita G; Battaglia F
    Biol Psychiatry; 2010 Mar; 67(6):558-66. PubMed ID: 20185032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered astrocyte calcium homeostasis and proliferation in theTs65Dn mouse, a model of Down syndrome.
    Bambrick LL; Yarowsky PJ; Krueger BK
    J Neurosci Res; 2003 Jul; 73(1):89-94. PubMed ID: 12815712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down syndrome mouse models are looking up.
    Reeves RH
    Trends Mol Med; 2006 Jun; 12(6):237-40. PubMed ID: 16677859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.
    Donovan MH; Yazdani U; Norris RD; Games D; German DC; Eisch AJ
    J Comp Neurol; 2006 Mar; 495(1):70-83. PubMed ID: 16432899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
    Rachidi M; Lopes C
    Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ectonucleotidases alkaline phosphatase and nucleoside triphosphate diphosphohydrolase 2 are associated with subsets of progenitor cell populations in the mouse embryonic, postnatal and adult neurogenic zones.
    Langer D; Ikehara Y; Takebayashi H; Hawkes R; Zimmermann H
    Neuroscience; 2007 Dec; 150(4):863-79. PubMed ID: 18031938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease.
    Tang J; Song M; Wang Y; Fan X; Xu H; Bai Y
    Biochem Biophys Res Commun; 2009 Jul; 385(3):341-5. PubMed ID: 19463786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome.
    Clark S; Schwalbe J; Stasko MR; Yarowsky PJ; Costa AC
    Exp Neurol; 2006 Jul; 200(1):256-61. PubMed ID: 16624293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.